A Non-Inferiority Prospective Randomized Multicenter Clinical Control Study of Hysteroscopic Repeat Curettage as the Primal Management of Low-risk Postmolar Gestational Trophoblastic Neoplasia
Who is this study for? Patients with Gestational Trophoblastic Neoplasias
Status: Recruiting
Location: See location...
Intervention Type: Procedure, Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
Study of hysteroscopic repeat curettage as the first-line treatment in low-risk postmolar gestational trophoblastic neoplasia compared with the MTX single drug chemotherapy
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 12
Maximum Age: 60
Healthy Volunteers: f
View:
• low-risk postmolar gestational trophoblastic neoplasia (GTN)
• World Health Organization(WHO) risk score≤4
• Age≤60 years; female, Chinese women
• Initial treatment
• Performance status: Karnofsky score≥60
• Laboratory tests: WBC≥3.5×10(9)/L, ANC≥1.5×10(9)/L, PLT≥80×10(9)/L, serum bilirubin≤ 1.5 times the upper limit of normal, transaminase≤ 1.5 times the upper limit of normal,blood urea nitrogen, Cr≤ normal
• Provide written informed consent.
Locations
Other Locations
China
Weiguo Lv
RECRUITING
Hangzhou
Time Frame
Start Date: 2019-03-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 70
Treatments
Active_comparator: chemotherapy
Methotrexate 0.4mg/kg·d, im ,\*5d started at the first day of cycle, two weeks a cycle
Experimental: study group
hysteroscopic repeat curettage
Related Therapeutic Areas
Sponsors
Leads: Women's Hospital School Of Medicine Zhejiang University
Collaborators: Qilu Hospital of Shandong University, Sun Yat-sen University, Huazhong University of Science and Technology